NCT00108290View on ClinicalTrials.gov

Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

April 30, 2004

Study Completion Date

March 31, 2007

Conditions

Prostate Cancer

Interventions

DRUG

Chemotherapy

Trial Locations (1)

21201

VA Maryland Health Care System, Baltimore

All Listed Sponsors

lead

US Department of Veterans Affairs

FED

NCT00108290 - Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer | Biotech Hunter | Biotech Hunter